Ruxolitinib v léčbě primární myelofibrózy
| Title in English | Ruxolitinib in the treatment of primary myelofibrosis |
|---|---|
| Authors | |
| Year of publication | 2013 |
| Type | Article in Periodical |
| Magazine / Source | Farmakoterapie |
| MU Faculty or unit | |
| Citation | |
| Web | http://www.farmakoterapie.cz/c3631/ruxolitinib-v-lecbe-primarni-myelofibrozy |
| Field | Oncology and hematology |
| Keywords | Janus kinases; primary myelofibrosis; ruxolitinib |
| Attached files | |
| Description | Treatment of primary myeolofibrosis is still far from successful. This condition has the worst prognosis in the group of myeloproliferative disorders. The patients are very frequently in advanced age and cannot therefore be offered allogeneic bone marrow transplantation. |
| Related projects: |